2020 ICD-10-CM Diagnosis Code P04.15

Newborn affected by maternal use of antidepressants

    2019 - New Code 2020 Billable/Specific Code Code on Newborn Record
  • P04.15 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2020 edition of ICD-10-CM P04.15 became effective on October 1, 2019.
  • This is the American ICD-10-CM version of P04.15 - other international versions of ICD-10 P04.15 may differ.
ICD-10-CM Coding Rules
  • P04.15 should be used on the newborn record - not on the maternal record.
The following code(s) above P04.15 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to P04.15:
  • P00-P96
    2020 ICD-10-CM Range P00-P96

    Certain conditions originating in the perinatal period

    Includes
    • conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later
    Note
    • Codes from this chapter are for use on newborn records only, never on maternal records
    Type 2 Excludes
    • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
    • endocrine, nutritional and metabolic diseases (E00-E88)
    • injury, poisoning and certain other consequences of external causes (S00-T88)
    • neoplasms (C00-D49)
    • tetanus neonatorum (A33)
    Certain conditions originating in the perinatal period
  • P00-P04
    2020 ICD-10-CM Range P00-P04

    Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery

    Note
    • These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth).
    Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery
  • P04
    ICD-10-CM Diagnosis Code P04

    Newborn affected by noxious substances transmitted via placenta or breast milk

      2016 2017 - Revised Code 2018 2019 2020 Non-Billable/Non-Specific Code
    Includes
    • nonteratogenic effects of substances transmitted via placenta
    Type 2 Excludes
    • congenital malformations (Q00-Q99)
    • encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
    • neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
    • newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
    Newborn affected by noxious substances transmitted via placenta or breast milk
  • P04.1
    ICD-10-CM Diagnosis Code P04.1

    Newborn affected by other maternal medication

      2016 2017 - Revised Code 2018 2019 - Converted to Parent Code 2020 Non-Billable/Non-Specific Code
    Code First
    • withdrawal symptoms from maternal use of drugs of addiction, if applicable (P96.1)
    Type 1 Excludes
    • dysmorphism due to warfarin (Q86.2)
    • fetal hydantoin syndrome (Q86.1)
    Type 2 Excludes
    • maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)
    • maternal use of drugs of addiction (P04.4-)
    Newborn affected by other maternal medication
ICD-10-CM P04.15 is grouped within Diagnostic Related Group(s) (MS-DRG v37.0):
  • 794 Neonate with other significant problems
Code History
  • 2019 (effective 10/1/2018): New code
  • 2020 (effective 10/1/2019): No change

Diagnosis Index entries containing back-references to P04.15:
  • Newborn (infant) (liveborn) (singleton) Z38.2
    ICD-10-CM Diagnosis Code Z38.2

    Single liveborn infant, unspecified as to place of birth

      2016 2017 2018 2019 2020 Billable/Specific Code Newborn/Neonate Dx (0 years) POA Exempt
    Applicable To
    • Single liveborn infant NOS

ICD-10-CM Codes Adjacent To P04.15
P03.82 Meconium passage during delivery
P03.89 Newborn affected by other specified complications of labor and delivery
P03.9 Newborn affected by complication of labor and delivery, unspecified
P04 Newborn affected by noxious substances transmitted via placenta or breast milk
P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
P04.1 Newborn affected by other maternal medication
P04.11 Newborn affected by maternal antineoplastic chemotherapy
P04.12 Newborn affected by maternal cytotoxic drugs
P04.13 Newborn affected by maternal use of anticonvulsants
P04.14 Newborn affected by maternal use of opiates
P04.15 Newborn affected by maternal use of antidepressants
P04.16 Newborn affected by maternal use of amphetamines
P04.17 Newborn affected by maternal use of sedative-hypnotics
P04.1A Newborn affected by maternal use of anxiolytics
P04.18 Newborn affected by other maternal medication
P04.19 Newborn affected by maternal use of unspecified medication
P04.2 Newborn affected by maternal use of tobacco
P04.3 Newborn affected by maternal use of alcohol
P04.4 Newborn affected by maternal use of drugs of addiction
P04.40 Newborn affected by maternal use of unspecified drugs of addiction
P04.41 Newborn affected by maternal use of cocaine

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.